FDA 503B outsourcing facilities in Tennessee
Tennessee has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, none with FDA drug recalls on record, the earliest registered in 2016. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| University of Tennessee | Memphis | 2024 | None on record |
| Wells Pharmacy, Inc. | Dyersburg | 2016 | None on record |
503B compounding in Tennessee
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Tennessee must hold the appropriate state pharmacy license. Verify any facility's current license with the Tennessee Board of Pharmacy.
Compounded peptides and GLP-1s
503B facilities are a primary supply route for compounded peptides and GLP-1s, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the full GLP-1 and therapeutic peptide databases, or the national directory.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Tennessee?
2 FDA-registered 503B outsourcing facilities are listed in Tennessee on PeptideGrids, the earliest registered in 2016.
Which Tennessee 503B facilities have FDA recalls on record?
None of the Tennessee facilities in our directory have FDA drug recalls on record.
How do I verify a pharmacy license in Tennessee?
Use the Tennessee Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.